HIV vaccine efficacy study launched in SA, ahead of World Aids Day
30 November 2016 - 12:58
THE world’s first HIV vaccine efficacy study to launch in seven years began at South African research sites on Wednesday‚ ahead of World Aids Day. The study‚ called HVTN 702‚ will determine whether an experimental vaccine regimen safely prevents HIV infection among South African adults.
ADVERTISING ADVERTISING..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.